Pegvisomant Interactions
There are 74 drugs known to interact with pegvisomant, along with 2 disease interactions. Of the total drug interactions, 74 are moderate.
- View all 74 medications that may interact with pegvisomant
- View pegvisomant disease interactions (2)
Most frequently checked interactions
View interaction reports for pegvisomant and the medicines listed below.
- Acetylsalicylic Acid (aspirin)
- Activated Charcoal (charcoal)
- Aldara (imiquimod topical)
- Andexxa (coagulation factor Xa)
- Apokyn (apomorphine)
- Blocadren (timolol)
- Co-trimoxazole (sulfamethoxazole / trimethoprim)
- Coenzyme Q10 (ubiquinone)
- Comtan (entacapone)
- Copper (copper gluconate)
- Dextrose (glucose)
- Dilacor XR (diltiazem)
- Diltiazem Hydrochloride SR (diltiazem)
- Duopa (carbidopa / levodopa)
- Entresto (sacubitril / valsartan)
- Epivir (lamivudine)
- Esbriet (pirfenidone)
- Feiba (anti-inhibitor coagulant complex)
- Genarc (antihemophilic factor)
- Givlaari (givosiran)
- Glycerol (glycerin)
- Heparin Sodium (heparin)
- Implanon (etonogestrel)
- Indium In-111 DTPA (indium pentetate in-111)
- InnoPran XL (propranolol)
- Iodides (sodium iodide)
- Jynarque (tolvaptan)
- Kalydeco (ivacaftor)
- L-Arginine (arginine)
- Paracetamol (acetaminophen)
Pegvisomant disease interactions
There are 2 disease interactions with pegvisomant which include:
Report options
QR code containing a link to this page
More about pegvisomant
- pegvisomant consumer information
- Compare alternatives
- Reviews (4)
- Side effects
- Dosage information
- During pregnancy
- Drug class: growth hormone receptor blockers
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
